Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for alcohol dependent and hazardous drinking prisoners with HIV who are transitioning to the community.

Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for alcohol dependent and hazardous drinking prisoners with HIV who are transitioning to the community.

Item
http://www.wikidata.org/entity/Q37712289
An evaluation of hepatic enzyme elevations among HIV-infected released prisoners enrolled in two randomized placebo-controlled trials of extended release naltrexone.Alcohol use disorders negatively influence antiretroviral medication adherence among men who have sex with men in Peru.Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for HIV-infected, opioid dependent prisoners and jail detainees who are transitioning to the community.Neural correlates of adherence to extended-release naltrexone pharmacotherapy in heroin dependenceIncarceration of people living with HIV/AIDS: implications for treatment-as-prevention.Correlates of retention on extended-release naltrexone among persons living with HIV infection transitioning to the community from the criminal justice system.A Qualitative Assessment of Alcohol Consumption and Sexual Risk Behaviors Among Men Who Have Sex With Men and Transgender Women in Peru.The Influence of Neurocognitive Impairment, Depression, and Alcohol Use Disorders on Health-Related Quality of Life among Incarcerated, HIV-Infected, Opioid Dependent Malaysian Men: A Moderated Mediation Analysis.Extended-release naltrexone reduces alcohol consumption among released prisoners with HIV disease as they transition to the community.Patient preferences and extended-release naltrexone: A new opportunity to treat opioid use disorders in Ukraine.Strategies for hepatitis C testing and linkage to care for vulnerable populations: point-of-care and standard HCV testing in a mobile medical clinic.Extended-Release Naltrexone Improves Viral Suppression among Incarcerated Persons Living with HIV with Opioid Use Disorders Transitioning to the Community: Results of a Double-Blind, Placebo-Controlled Randomized Trial.A qualitative assessment of attitudes about and preferences for extended-release naltrexone, a new pharmacotherapy to treat opioid use disorders in Ukraine.
P2860

Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for alcohol dependent and hazardous drinking prisoners with HIV who are transitioning to the community.

Item
http://www.wikidata.org/entity/Q37712289
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Design and methods of a double ...... ransitioning to the community.
@en
Design and methods of a double ...... ransitioning to the community.
@nl
type
label
Design and methods of a double ...... ransitioning to the community.
@en
Design and methods of a double ...... ransitioning to the community.
@nl
prefLabel
Design and methods of a double ...... ransitioning to the community.
@en
Design and methods of a double ...... ransitioning to the community.
@nl
P1433
P1476
P2093
P2507
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Design and methods of a double ...... ransitioning to the community.
@en
P2093
P2507
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P932